Professional Institutional Original Effective Date: October 17, 2006 Original Effective Date: May 1, 2007 Revision Date(s): January 20, 2007; April 1, 2007; September 25, 2007; June 26, 2008; January 1, 2009; June 30, 2009; February 25, 2011; January 15, 2013; March 27, 2014; January 21, 2016; December 20, 2017 Revision Date(s): September 25, 2007; June 26, 2008; January 1, 2009; June 30, 2009;...

OBJECTIVE Our survey assessed the use of advanced radiotherapy technologies at the designated cancer care hospitals in Japan, and we identified several issues to be addressed. METHODS We collected the data of 397 designated cancer care hospitals, including information on staffing in the department of radiation oncology (e.g. radiation oncologists, medical physicists and radiation therapists),...

High local control and low toxicity rates are seen in patients treated with stereotactic body radiotherapy (SBRT) for peripheral lung tumours [1,2]. According to the Advisory Committee on Radiation...

OBJECTIVE To describe and synthesize the current stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) cost-effectiveness research to date across several common SRS and SBRT applications. METHODS This review was limited to comparative economic evaluations of SRS, SBRT, and alternative treatments (e.g., other radiotherapy techniques or surgery). Based on PubMed searche...

BACKGROUND Oligometastases can be divided into sync-oligometastases and oligo-recurrence. The difference is whether the primary site is uncontrolled or controlled. The goal of this multicenter study was to evaluate treatment outcomes and factors affecting survival after stereotactic body radiotherapy for pulmonary oligometastases. METHODS The information after stereotactic body radiotherapy f...

Submitted Volumetric modulated arc therapy for stereotactic body radiotherapy: Planning considerations, delivery accuracy and efficiency